ITOLERANCE
iTolerance is a biotechnology company focused on regenerative medicine without immunosuppression. The company was founded in 2020 and is headquartered in Santa Barbara, CA.
ITOLERANCE
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2020-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.itolerance.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Trishula Therapeutics
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.itolerance.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "iTolerance"
Management Team - iTolerance, Inc.
Importantly, in relation to iTolerance, she is the co-inventor of the SA-FasL microgel technology and the co-author of the Company’s recently published Science Advances manuscript. …See details»
iTolerance - Crunchbase Company Profile & Funding
ITolerance is a biotechnology company focused on regenerative medicine …See details»
iTolerance 2025 Company Profile: Valuation, Funding
ITolerance General Information Description. Operator of a data-driven and …See details»
Itolerance, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 About About iTolerance, Inc. iTolerance is an early-stage privately-held regenerative medicine company developing technologies to enable tissue, organoid or cell …See details»
iTolerance - 2025 Company Profile & Competitors - Tracxn
ITolerance is an unfunded company based in Miami (United States), founded in 2020. It operates as a Developer of cell therapies to treat diabetes and liver failure. iTolerance has not raised …See details»
iTolerance - The Org
ITolerance is a privately-held regenerative medicine company enabling tissue, organoid, or cell therapy without the need for life-long immunosuppression. Industries. Biotechnology. …See details»
Collaborators - iTolerance, Inc.
ITolerance, Inc. has an established indirect cost rate at 30% of direct costs for all of our industry-sponsored research grants to universities. ... We are an …See details»
iTolerance, Inc. and Northway Biotech Announce Partnership …
Aug 1, 2023 iTolerance Contacts: Investor Contact Jenene Thomas Chief Executive Officer JTC Team, LLC T: 833.475.8247 [email protected]. Media Contact Susan Roberts T: …See details»
iTolerance:Company Profile & Technical Research,Competitor …
ITolerance is a company that provides Health care, Biology and more. iTolerance is headquartered in United States Florida. iTolerance was founded in 2020. and was founded by …See details»
iTolerance, Inc., a Company Pioneering Regenerative Medicine …
ITolerance isa privately held biotechnology company focused on the development of innovative regenerative medicines. The Company’s lead program, ITOL-101, is an adjunct therapy with …See details»
iTolerance, Inc. Awarded Industry Discovery and Development …
Jun 28, 2022 (“iTolerance” or the “Company”), an early-stage regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long …See details»
Careers - iTolerance, Inc.
Cookie Duration Description; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in …See details»
iTolerance, Inc. Selected to Participate in a Disruptive Healthcare ...
Jun 21, 2023 Lead program, iTOL-102, in development as a cure for Type 1 diabetes Company pioneering regenerative medicine without immunosuppression to treat other diseases MIAMI, …See details»
iTolerance | Miami FL - Facebook
Jun 20, 2025 iTolerance, Miami, Florida. 159 likes · 14 talking about this. iTolerance is a privately held regenerative medicine company enabling tissue, ... #DiabetesAwareness …See details»
Scientific Advisory Board - iTolerance, Inc.
This concept generated over a dozen of patents that have been licensed by FasCure Therapeutics and iTolerance. Dr. Shirwan is also assessing various vehicles, including live …See details»
Anthony Japour - iTOLERANCE, Inc. | LinkedIn
Seasoned physician, Biotech and Pharmaceutical Executive with over 30 years experience… · Experience: iTOLERANCE, Inc. · Education: Harvard Medical School · Location: Miami · 500 ...See details»
iTolerance, Inc. and Northway Biotech Announce Partnership …
Aug 1, 2023 MIAMI, FL and VILNIUS, Lithuania – August 1, 2023 – iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage regenerative medicine company developing technologies to …See details»
I Tolerance - Company Info, Employees & Competitors
View Itolerance itolerance.com location in Miami, florida, 33136, united states, revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
iTOL-401 - Drug Targets, Indications, Patents - Synapse
May 7, 2025 The submission is a significant milestone toward the clinical development of iTOL102, an on-going collaborative research initiative between iTolerance and Kadimastem, …See details»
iTolerance, Inc. and Northway Biotech Announce Partnership …
Aug 1, 2023 MIAMI, FL & VILNIUS, LITHUANIA, Aug 1, 2023 - (ACN Newswire) - iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company …See details»